Adenosine receptor ligands: differences with acute versus chronic treatment
- 1 March 1996
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 17 (3) , 108-113
- https://doi.org/10.1016/0165-6147(96)10002-x
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- CGS 15943, An adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the mongolian gerbilLife Sciences, 1994
- Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functionsTrends in Pharmacological Sciences, 1994
- Action of caffeine, L-PIA and their combination of memory retention in the ratLife Sciences, 1994
- Effects of combinations of methylxanthines and adenosine analogs on locomotor activity in control and chronic caffeine‐treated miceDrug Development Research, 1993
- Chronic theophylline prolongs the refractory period in amygdala‐kindled ratsDrug Development Research, 1993
- Selective A1-Antagonists for Treatment of Cognitive DeficitsNucleosides and Nucleotides, 1991
- N-methyl-D-aspartate antagonists and working memory performance: Comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosine.Behavioral Neuroscience, 1991
- Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatmentNeuroscience Letters, 1989
- Temporal relationship between A1 adenosine receptor upregulation and alterations in bicuculline seizure susceptibility in ratsNeuroscience Letters, 1989
- Cross-tolerance studies between caffeine and (−)-N6-(phenylisopropyl)-adenosine (PIA) in miceLife Sciences, 1986